Setting

North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

Published: 31 Mar 2022 | Report Code: 10248441 | Pages: 102

North America DNA sequencing market is projected to grow by 14.8% annually in the forecast period and reach $20,330.9 million by 2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction. Highlighted with 22 tables and 53 figures, this 102-page report “North America DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Sequencing Services Based on Sequencing Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sanger Sequencing • Next Generation Sequencing • Other Sequencing Types By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sequencing by Synthesis • Ion Semiconductor Sequencing • Chain Termination Sequencing • Pyrosequencing • Sequencing by Ligation (SBL) • Single-Molecule Real-Time Sequencing (SMRT) • Nanopore Sequencing • Other Technologies By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomarker Discovery • Diagnostics • Personalized Medicine • Reproductive Health • Forensics • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Academics and Research Organizations • Pharmaceutical and Biotechnology Companies • Hospitals & Clinics • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Agilent Technologies Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories Inc. Danaher Corporation (Integrated DNA Technologies Inc.) Eurofins Scientific SE F. Hoffmann-La Roche Ltd. Illumina Inc. Merck KGaA Pacific Biosciences of California Inc. PerkinElmer Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

7 1.1 Industry Definition and Research Scope 7 1.1.1 Industry Definition 7 1.1.2 Research Scope 8 1.2 Research Methodology 11 1.2.1 Overview of Market Research Methodology 11 1.2.2 Market Assumption 12 1.2.3 Secondary Data 12 1.2.4 Primary Data 12 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 20 2.1.2 Impact of COVID-19 on the Market 22 2.2 Major Growth Drivers 24 2.3 Market Restraints and Challenges 31 2.4 Emerging Opportunities and Market Trends 34 2.5 Porter’s Fiver Forces Analysis 38 3 Segmentation of North America Market by Offering 42 3.1 Market Overview by Offering 42 3.2 Instruments 44 3.3 Consumables 45 3.4 Sequencing Services 46 4 Segmentation of North America Market by Sequencing Type 47 4.1 Market Overview by Sequencing Type 47 4.2 Sanger Sequencing 49 4.3 Next Generation Sequencing 50 4.4 Other Sequencing Types 51 5 Segmentation of North America Market by Technology 52 5.1 Market Overview by Technology 52 5.2 Sequencing by Synthesis 54 5.3 Ion Semiconductor Sequencing 55 5.4 Chain Termination Sequencing 56 5.5 Pyrosequencing 57 5.6 Sequencing by Ligation (SBL) 58 5.7 Single-Molecule Real-Time Sequencing (SMRT) 59 5.8 Nanopore Sequencing 60 5.9 Other Technologies 61 6 Segmentation of North America Market by Application 62 6.1 Market Overview by Application 62 6.2 Biomarker Discovery 64 6.3 Diagnostics 65 6.4 Personalized Medicine 66 6.5 Reproductive Health 67 6.6 Forensics 68 6.7 Other Applications 69 7 Segmentation of North America Market by End User 70 7.1 Market Overview by End User 70 7.2 Academics and Research Organizations 72 7.3 Pharmaceutical and Biotechnology Companies 73 7.4 Hospitals & Clinics 74 7.5 Other End Users 75 8 North America Market 2021-2031 by Country 76 8.1 Overview of North America Market 76 8.2 U.S. 79 8.3 Canada 82 8.4 Mexico 84 9 Competitive Landscape 86 9.1 Overview of Key Vendors 86 9.2 New Product Launch, Partnership, Investment, and M&A 89 9.3 Company Profiles 90 Agilent Technologies Inc. 90 BGI Genomics Co., Ltd. 92 Bio-Rad Laboratories Inc. 93 Danaher Corporation (Integrated DNA Technologies Inc.) 94 Eurofins Scientific SE 95 F. Hoffmann-La Roche Ltd. 96 Illumina Inc. 97 Merck KGaA 98 Pacific Biosciences of California Inc. 99 PerkinElmer Inc. 100 Thermo Fisher Scientific Inc. 101 RELATED REPORTS 102
List Of Tables:
Table 1. Snapshot of North America DNA Sequencing Market in Balanced Perspective, 2021-2031 17 Table 2. World Economic Outlook, 2021-2031 21 Table 3. World Health Spending by Region, $ bn, 2013-2020 30 Table 4. Main Product Trends and Market Opportunities in North America DNA Sequencing Market 34 Table 5. North America DNA Sequencing Market by Offering, 2021-2031, $ mn 42 Table 6. North America DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 47 Table 7. North America DNA Sequencing Market by Technology, 2021-2031, $ mn 52 Table 8. North America DNA Sequencing Market by Application, 2021-2031, $ mn 62 Table 9. North America DNA Sequencing Market by End User, 2021-2031, $ mn 70 Table 10. North America DNA Sequencing Market by Country, 2021-2031, $ mn 77 Table 11. U.S. DNA Sequencing Market by Offering, 2021-2031, $ mn 81 Table 12. U.S. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 81 Table 13. U.S. DNA Sequencing Market by End User, 2021-2031, $ mn 81 Table 14. Canada DNA Sequencing Market by Offering, 2021-2031, $ mn 83 Table 15. Canada DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 83 Table 16. Canada DNA Sequencing Market by End User, 2021-2031, $ mn 83 Table 17. Mexico DNA Sequencing Market by Offering, 2021-2031, $ mn 85 Table 18. Mexico DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 85 Table 19. Mexico DNA Sequencing Market by End User, 2021-2031, $ mn 85 Table 20. Agilent Technologies Inc.: Company Snapshot 90 Table 21. Agilent Technologies Inc.: Business Segmentation 91 Table 22. Agilent Technologies Inc.: Product Portfolio 91
List Of Figures:
Figure 1. Research Method Flow Chart 11 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14 Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16 Figure 4. North America DNA Sequencing Market, 2021-2031, $ mn 19 Figure 5. Impact of COVID-19 on Business 22 Figure 6. Primary Drivers and Impact Factors of North America DNA Sequencing Market 24 Figure 7. World Number of Deaths by Cause in 2017 27 Figure 8. World Number of Deaths from Cancers in 2017 28 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 29 Figure 11. Primary Restraints and Impact Factors of North America DNA Sequencing Market 31 Figure 12. Investment Opportunity Analysis 35 Figure 13. Porter’s Fiver Forces Analysis of North America DNA Sequencing Market 38 Figure 14. Breakdown of North America DNA Sequencing Market by Offering, 2021-2031, % of Revenue 43 Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 43 Figure 16. North America DNA Sequencing Market by Offering: Instruments, 2021-2031, $ mn 44 Figure 17. North America DNA Sequencing Market by Offering: Consumables, 2021-2031, $ mn 45 Figure 18. North America DNA Sequencing Market by Offering: Sequencing Services, 2021-2031, $ mn 46 Figure 19. Breakdown of North America DNA Sequencing Market by Sequencing Type, 2021-2031, % of Sales Revenue 48 Figure 20. North America Addressable Market Cap in 2022-2031 by Sequencing Type, Value ($ mn) and Share (%) 48 Figure 21. North America DNA Sequencing Market by Sequencing Type: Sanger Sequencing, 2021-2031, $ mn 49 Figure 22. North America DNA Sequencing Market by Sequencing Type: Next Generation Sequencing, 2021-2031, $ mn 50 Figure 23. North America DNA Sequencing Market by Sequencing Type: Other Sequencing Types, 2021-2031, $ mn 51 Figure 24. Breakdown of North America DNA Sequencing Market by Technology, 2021-2031, % of Sales Revenue 53 Figure 25. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 53 Figure 26. North America DNA Sequencing Market by Technology: Sequencing by Synthesis, 2021-2031, $ mn 54 Figure 27. North America DNA Sequencing Market by Technology: Ion Semiconductor Sequencing, 2021-2031, $ mn 55 Figure 28. North America DNA Sequencing Market by Technology: Chain Termination Sequencing, 2021-2031, $ mn 56 Figure 29. North America DNA Sequencing Market by Technology: Pyrosequencing, 2021-2031, $ mn 57 Figure 30. North America DNA Sequencing Market by Technology: Sequencing by Ligation (SBL), 2021-2031, $ mn 58 Figure 31. North America DNA Sequencing Market by Technology: Single-Molecule Real-Time Sequencing (SMRT), 2021-2031, $ mn 59 Figure 32. North America DNA Sequencing Market by Technology: Nanopore Sequencing, 2021-2031, $ mn 60 Figure 33. North America DNA Sequencing Market by Technology: Other Technologies, 2021-2031, $ mn 61 Figure 34. Breakdown of North America DNA Sequencing Market by Application, 2021-2031, % of Revenue 63 Figure 35. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63 Figure 36. North America DNA Sequencing Market by Application: Biomarker Discovery, 2021-2031, $ mn 64 Figure 37. North America DNA Sequencing Market by Application: Diagnostics, 2021-2031, $ mn 65 Figure 38. North America DNA Sequencing Market by Application: Personalized Medicine, 2021-2031, $ mn 66 Figure 39. North America DNA Sequencing Market by Application: Reproductive Health, 2021-2031, $ mn 67 Figure 40. North America DNA Sequencing Market by Application: Forensics, 2021-2031, $ mn 68 Figure 41. North America DNA Sequencing Market by Application: Other Applications, 2021-2031, $ mn 69 Figure 42. Breakdown of North America DNA Sequencing Market by End User, 2021-2031, % of Revenue 71 Figure 43. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71 Figure 44. North America DNA Sequencing Market by End User: Academics and Research Organizations, 2021-2031, $ mn 72 Figure 45. North America DNA Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 73 Figure 46. North America DNA Sequencing Market by End User: Hospitals & Clinics, 2021-2031, $ mn 74 Figure 47. North America DNA Sequencing Market by End User: Other End Users, 2021-2031, $ mn 75 Figure 48. Breakdown of North America DNA Sequencing Market by Country, 2021 and 2031, % of Revenue 77 Figure 49. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78 Figure 50. U.S. DNA Sequencing Market, 2021-2031, $ mn 80 Figure 51. Canada DNA Sequencing Market, 2021-2031, $ mn 82 Figure 52. DNA Sequencing Market in Mexico, 2021-2031, $ mn 84 Figure 53. Growth Stage of North America DNA Sequencing Industry over the Forecast Period 86
Selected Key Players: 
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)